Launching a dramatic expansion of government support for one of the most promising but most contentious fields of biomedical research, the National Institutes of Health on Wednesday [last week] authorized the first 13 lines of cells under the administration's policy and was poised to approve 20 more Friday...
The NIH has already authorized 31 grants worth about $21 million for research on human embryonic stem cells, money that was contingent on new lines passing government muster. The grants are for a variety of research, including work aimed at developing cells that could be used to treat diseases of the heart and nervous system.
This is an excerpt from a December 3 story in the Washington Post. Read the full story here.
